GC Genome Corporation (KOSDAQ:340450)
7,700.00
+70.00 (0.92%)
At close: Dec 5, 2025
GC Genome Market Cap
GC Genome has a market cap or net worth of 182.11 billion as of December 5, 2025.
Market Cap
182.11B
Enterprise Value
144.85B
Revenue
30.79B
Ranking
n/a
PE Ratio
65.04
Stock Price
7,700.00
Market Cap Chart
Since June 11, 2025, GC Genome's market cap has decreased from 262.52B to 182.11B, a decrease of -30.63%. That is a compound annual growth rate of -52.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 182.11B | -30.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8,755.13B |
| LigaChem Biosciences | 6,753.15B |
| Peptron | 6,645.44B |